RMC No. 66-2022: Updated VAT-Exempt Medical Devices for COVID-19 Treatment Under the CREATE Act

RMC No. 66-2022 updates the FDA-endorsed VAT-exempt list for certain COVID-19 treatment medical devices under the CREATE Act. Businesses selling, importing, purchasing, or claiming VAT treatment on COVID-19-related medical devices must immediately check whether their products remain covered by the updated VAT-exempt list endorsed by the Food and Drug Administration. RMC No. 66-2022 matters because […]